KRX-211

N/A

Report date: 2024/12/05 15:15:14
NME

Base Information

Drug NameKRX-211
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsArthritis, RheumatoidShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeryx Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeryx Biopharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A